Analysis and Commentary STEVEN GROSSMAN 9/14/18 Analysis and Commentary STEVEN GROSSMAN 9/14/18 Three Possible Ways to Hatch an Egg Read More STEVEN GROSSMAN 9/7/18 STEVEN GROSSMAN 9/7/18 Timing, Knowns, and Unknowns: FDA's FY 19 Appropriation Read More Advocacy at a Glance STEVEN GROSSMAN 9/7/18 Advocacy at a Glance STEVEN GROSSMAN 9/7/18 Congress Returns; Appropriations Bills Advance and more Read More Analysis and Commentary STEVEN GROSSMAN 7/13/18 Analysis and Commentary STEVEN GROSSMAN 7/13/18 Our Advocacy Remains an Imperative for Strong Funding Read More Advocacy at a Glance STEVEN GROSSMAN 6/29/18 Advocacy at a Glance STEVEN GROSSMAN 6/29/18 Last Chance to Join Alliance Sign-On Letter to Appropriators and more Read More Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Senate Appropriations Committee Votes for FY 18 FDA Funding at FY 17 Levels and more Read More Analysis and Commentary STEVEN GROSSMAN 10/14/16 Analysis and Commentary STEVEN GROSSMAN 10/14/16 And Now Much Depends on Election Day Outcomes Read More Analysis and Commentary STEVEN GROSSMAN 9/9/16 Analysis and Commentary STEVEN GROSSMAN 9/9/16 Omnibus, Minibus, or Any Type of Bus at All? Read More
Analysis and Commentary STEVEN GROSSMAN 9/14/18 Analysis and Commentary STEVEN GROSSMAN 9/14/18 Three Possible Ways to Hatch an Egg Read More
STEVEN GROSSMAN 9/7/18 STEVEN GROSSMAN 9/7/18 Timing, Knowns, and Unknowns: FDA's FY 19 Appropriation Read More
Advocacy at a Glance STEVEN GROSSMAN 9/7/18 Advocacy at a Glance STEVEN GROSSMAN 9/7/18 Congress Returns; Appropriations Bills Advance and more Read More
Analysis and Commentary STEVEN GROSSMAN 7/13/18 Analysis and Commentary STEVEN GROSSMAN 7/13/18 Our Advocacy Remains an Imperative for Strong Funding Read More
Advocacy at a Glance STEVEN GROSSMAN 6/29/18 Advocacy at a Glance STEVEN GROSSMAN 6/29/18 Last Chance to Join Alliance Sign-On Letter to Appropriators and more Read More
Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Senate Appropriations Committee Votes for FY 18 FDA Funding at FY 17 Levels and more Read More
Analysis and Commentary STEVEN GROSSMAN 10/14/16 Analysis and Commentary STEVEN GROSSMAN 10/14/16 And Now Much Depends on Election Day Outcomes Read More
Analysis and Commentary STEVEN GROSSMAN 9/9/16 Analysis and Commentary STEVEN GROSSMAN 9/9/16 Omnibus, Minibus, or Any Type of Bus at All? Read More
